| Financial Year |
March 31 2023 |
| Monetary Funds |
330,471,745.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
350,000.00 |
| Accounts Receivable |
79,960,077.69 |
| Advances to Suppliers |
31,632,220.92 |
| Other Receivables |
15,313,606.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
134,293,715.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,290,351.05 |
| Total Current Assets |
601,311,717.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
22,885,948.65 |
| Fixed Assetes |
1,436,351,628.68 |
| Under-construction Projects |
17,772,525.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
108,554,475.97 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
138,123,875.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
26,795,317.33 |
| Deferred Income Tax Assets |
111,938,414.31 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,005,007,398.89 |
| Total Assets |
2,606,319,116.73 |
| Short-Term Loans |
194,013,109.73 |
| Trading Financial liabilities |
-- |
| Notes Payable |
149,449,185.12 |
| Accounts Payable |
282,460,756.16 |
| Accounts Received In Advance |
261,819.38 |
| Employee Compensation Payable |
51,632,901.06 |
| Taxes Payable |
10,867,825.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
67,300,726.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
89,249,815.72 |
| Other Current Liabilities |
42,359,347.60 |
| Sub-Total of Current Liabilities |
1,248,191,188.56 |
| Long-term Loans |
176,451,397.02 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,032,097.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
276,906,720.87 |
| Total Liabilities |
1,525,097,909.43 |
| Paid-In Capital(Or Share Stock) |
401,000,000.00 |
| Capital Surplus |
461,441,420.71 |
| Surplus Reserve |
93,093,487.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
125,299,160.48 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,081,221,207.30 |
| Owner's Equity（Stockholder's Equity） |
1,081,221,207.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,606,319,116.73 |
